ULURU INC TO PRESENT ALTRAZEAL™ CLINICAL EVIDENCE AT THE AMERICAN PODIATRIC MEDICAL ASSOCIATION (APMA) ANNUAL SCIENTIFIC MEETING IN TORONTO, CANADA

07/29/2009

Addison, Texas, July 29, 2009; ULURU Inc. (NYSE Alternext: ULU) announced today that the application of Altrazeal™ and best clinical practice will be demonstrated in a hands-on Wound Care Pre Conference Workshop at the APMA Annual Scientific Meeting July 28 - August 2. In addition, clinical evidence on the treatment of wounds using Altrazeal™ Transforming Powder Dressing will be presented on posters during the meeting. Read More